Dear PPMI Participants,
Your dedication to this new frontier of PD research is invaluable.
The time and effort you commit to the completion of this trial
will pay off as the worldwide community of Parkinson’s disease
researchers access this rock-solid, well-controlled data set. This
unprecedented effort would not have been possible without the
commitment of each individual. As a researcher and as a member
of MJFF’s Scientific Advisory Board, I would like to thank you
personally and assure you that the research community, starting
with my research unit focusing on neurodegenerative diseases,
will build upon your efforts to define the natural course of the
disease and hopefully identify reliable diagnostic and
prognostic biomarkers.
With my most sincere thanks,
Erwan Bezard, PhD
INSERM Research Director
Member, MJFF Scientific Advisory Board
“I know I speak for all of
us when I say, You are
our hero.”
Karen Jaffe, MD
Person with Young-Onset Parkinson’s
MJFF Patient Council
21